Direct Promoter Repression by BCL11A Controls the Fetal to Adult Hemoglobin Switch

Area of Science:

• Genetics
• Molecular Biology
• Hematology

Background:

• Fetal hemoglobin (HbF) levels genetically influence the severity of adult hemoglobin disorders like sickle cell disease and β-thalassemia.
• BCL11A is a key regulator of the developmental switch from fetal hemoglobin (γ-globin) to adult hemoglobin (β-globin).

Purpose of the Study:

• To elucidate the mechanism by which BCL11A mediates the developmental switch from γ-globin to β-globin expression.
• To identify the specific DNA sequences and protein domains involved in BCL11A-mediated repression of γ-globin genes.

Main Methods:

• Functional assays and protein binding microarrays were employed to identify BCL11A's DNA recognition sequence and functional domains.
• CUT&RUN assays were used to map BCL11A binding sites in erythroid cells.
• Promoter editing was utilized to assess the impact on BCL11A binding and gene expression.

Main Results:

• A zinc-finger cluster in BCL11A is essential for repressing γ-globin gene expression.
• A specific DNA motif recognized by BCL11A was identified in embryonic and fetal globin promoters, notably duplicated in γ-globin promoters.
• BCL11A preferentially binds to the distal motif in γ-globin promoters, and disrupting this binding affects gene expression.

Conclusions:

• Direct repression of the γ-globin gene promoter by BCL11A is the underlying mechanism of the hemoglobin switch.
• Understanding this BCL11A-mediated repression offers potential therapeutic targets for hemoglobinopathies.